Search Results

Filter
  • 1-10 of  139 results for ""Polycythemia Vera""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A phase II trial to assess the efficacy and safety of ropeginterferon α-2b in Chinese patients with polycythemia vera.

  • Authors : Jin J; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Qin A

Subjects: Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/drug therapy ; Interferon alpha-2*/Interferon alpha-2*/Interferon alpha-2*/therapeutic use; Humans

  • Source: Future oncology (London, England) [Future Oncol] 2023 Apr; Vol. 19 (11), pp. 753-761. Date of Electronic Publication: 2023 May 02.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Polycythemia vera complicated by chorea: A case report and the review of Chinese and international literature.

  • Authors : Raza HK; Department of Neurology, the Affiliated Hospital of Xuzhou Medical University, 221002 Xuzhou, China; School of International Education, Xuzhou Medical University, 221002 Xuzhou, China.

Subjects: Chorea*/Chorea*/Chorea*/diagnosis ; Chorea*/Chorea*/Chorea*/etiology ; Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/complications

  • Source: Revue neurologique [Rev Neurol (Paris)] 2021 Oct; Vol. 177 (8), pp. 1025-1030. Date of Electronic Publication: 2021 Mar 26.Publisher: Masson Country of Publication: France NLM ID: 2984779R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0035-3787

Record details

×
Academic Journal

[Health-related quality of life and its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms].

  • Authors : Bao M; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.; Shi DY

Subjects: Myeloproliferative Disorders* ; Polycythemia Vera*; Adult

  • Source: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 Dec 14; Vol. 42 (12), pp. 985-992.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 8212398 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Thrombosis among 1537 patients with JAK2 V617F -mutated myeloproliferative neoplasms: Risk factors and development of a predictive model.

  • Authors : Zhang Y; Department of Hematology, The Second Hospital of Tianjin Medical University, Tianjin, China.; Zhou Y

Subjects: Janus Kinase 2/Janus Kinase 2/Janus Kinase 2/*genetics ; Polycythemia Vera/Polycythemia Vera/Polycythemia Vera/*complications ; Primary Myelofibrosis/Primary Myelofibrosis/Primary Myelofibrosis/*complications

  • Source: Cancer medicine [Cancer Med] 2020 Mar; Vol. 9 (6), pp. 2096-2105. Date of Electronic Publication: 2020 Jan 28.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

[Survival and prognosis of patients with polycythemia vera: a study of 816 patients in a single Chinese center].

  • Authors : Bai J; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300020, China.; Shi H

Subjects: Polycythemia Vera* ; Primary Myelofibrosis*; Alleles

  • Source: Zhonghua yi xue za zhi [Zhonghua Yi Xue Za Zhi] 2015 May 12; Vol. 95 (18), pp. 1364-8.Publisher: Zhonghua yi xue hui Country of Publication: China NLM ID: 7511141 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential thrombocythemia myelofibrosis in the Chinese population.

  • Authors : Du X; Department of Hematology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.; Zhou D

Subjects: Polycythemia Vera/Polycythemia Vera/Polycythemia Vera/*complications ; Primary Myelofibrosis/Primary Myelofibrosis/Primary Myelofibrosis/*drug therapy ; Protein Kinase Inhibitors/Protein Kinase Inhibitors/Protein Kinase Inhibitors/*administration & dosage

  • Source: Frontiers of medicine [Front Med] 2016 Dec; Vol. 10 (4), pp. 437-443. Date of Electronic Publication: 2016 Dec 23.Publisher: Higher Education Press Country of Publication: China NLM ID: 101549428 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Risk factors of long-term incidences of thrombosis, myelofibrosis and evolution into malignance in polycythemia vera: a single center experience from China.

  • Authors : Bai J; Polycythemia Vera Studying Program, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, 288 Nanjing Road, 300020, Tianjin, People's Republic of China.; Xue Y

Subjects: Leukemia, Myeloid, Acute/Leukemia, Myeloid, Acute/Leukemia, Myeloid, Acute/*mortality ; Polycythemia Vera/Polycythemia Vera/Polycythemia Vera/*mortality ; Primary Myelofibrosis/Primary Myelofibrosis/Primary Myelofibrosis/*mortality

  • Source: International journal of hematology [Int J Hematol] 2008 Dec; Vol. 88 (5), pp. 530-535. Date of Electronic Publication: 2008 Nov 11.Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Clinicopathologic features and prognostic indicators in Chinese patients with myelofibrosis.

Subjects: Hematopoietic Stem Cell Transplantation*; Polycythemia Vera/Polycythemia Vera/Polycythemia Vera/*pathology ; Primary Myelofibrosis/Primary Myelofibrosis/Primary Myelofibrosis/*pathology

  • Source: Hematology (Amsterdam, Netherlands) [Hematology] 2016 Jan; Vol. 21 (1), pp. 10-8. Date of Electronic Publication: 2015 Aug 20.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Report

The investigation of JAK2 mutation in Chinese myeloproliferative diseases-identification of a novel C616Y point mutation in a PV patient.

Subjects: Mutation, Missense* ; Point Mutation*; Janus Kinase 2/Janus Kinase 2/Janus Kinase 2/*genetics

  • Source: International journal of laboratory hematology [Int J Lab Hematol] 2007 Feb; Vol. 29 (1), pp. 71-2.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 101300213 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
  • 1-10 of  139 results for ""Polycythemia Vera""